Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 10, Pages 1685
Publisher
MDPI AG
Online
2019-10-16
DOI
10.3390/jcm8101685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
- (2019) Charlotte E L Klaver et al. Lancet Gastroenterology & Hepatology
- Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
- (2016) Rebecca M. Dodson et al. ANNALS OF SURGICAL ONCOLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study
- (2014) Olivier Glehen et al. BMC CANCER
- Comparison Different Methods of Intraoperative and Intraperitoneal Chemotherapy for Patients with Gastric Cancer: A Meta-analysis
- (2013) Jin-Yu Huang et al. Asian Pacific Journal of Cancer Prevention
- Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases
- (2013) D. Elias et al. EUROPEAN JOURNAL OF CANCER
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials
- (2013) Deng-Hai Mi et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
- (2012) Jingxu Sun et al. BMC CANCER
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2012) Terence C. Chua et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of the 7th UICC TNM Staging System of Gastric Cancer
- (2011) Sung Joon Kwon Journal of Gastric Cancer
- Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
- (2010) Olivier Glehen et al. ANNALS OF SURGICAL ONCOLOGY
- Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- (2010) Dario Baratti World Journal of Gastrointestinal Oncology
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
- (2009) Tristan D. Yan et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperthermia adds to chemotherapy
- (2008) Rolf D. Issels EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started